 |
 |

COMMENTS AND OPINIONS
Hormone Therapy Use May Explain Recent Results Regarding Tumor Regression
Harald Weedon-Fekjær, PhD;
Ragnhild Sørum, MSc;
Marianne Kolstad Brenn, MSc
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In their article, Zahl et al1 suggest that many breast cancer tumors detected during mammographic screening discontinue their detectability thereafter and may spontaneously regress. They used ecological data to compare 2 different cohorts over 2 different calendar periods, reporting a relative rate of invasive breast cancer of 1.22 (95% confidence interval [CI]; 1.16-1.30) in women who had the opportunity to undergo 3 vs 1 screening examinations. The study, while novel in its design, unfortunately has substantial weaknesses.
The major concern with this result and the subsequent conclusion stems from a time-related differential in HT use in the 2 study cohorts (Figure). Breast cancer incidence has been shown to increase with HT use and is dependent on the estrogen-progesterone composition.2 Zahl et al1 performed a sensitivity analysis based on a study from the United States that reported a 24% . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
The Natural History of Invasive Breast Cancers Detected by Screening Mammography
Per-Henrik Zahl, Jan Mæhlen, and H. Gilbert Welch
Arch Intern Med. 2008;168(21):2311-2316.
ABSTRACT
| FULL TEXT
|